Compound Detail
CHEMBL30
CIMETIDINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL30 |
| Name | CIMETIDINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | AQIXAKUUQRKLND-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
17
Targets
64
Activities
3
Assay Types
18
PK Parameters
20
Publications
30
Known Names
17
Indications
1
Mechanisms
Molecular Properties
252.3
MW (Da)
0.60
ALogP
4
HBA
3
HBD
88.9
PSA (Ų)
0.23
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1977 |
| Availability | OTC |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Histamine H2 receptor antagonist | ANTAGONIST | Histamine H2 receptor | ✓ | ✓ |
Indications
Duodenal Ulcer Gastroesophageal Reflux Heartburn Peptic Ulcer Dermatitis, Atopic Gastrointestinal Hemorrhage Hemorrhage Ulcer Breast Carcinoma In Situ Breast Neoplasms Breast Neoplasms Endometrial Neoplasms Protoporphyria, Erythropoietic Amyotrophic Lateral Sclerosis Anxiety Disorders Infections Pulmonary Disease, Chronic Obstructive
ATC Classification
A02BA01
cimetidine
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS FOR ACID RELATED DISORDERS
A02BA51
cimetidine, combinations
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS FOR ACID RELATED DISORDERS
Activity Summary
IC50 32 meas. best 6.85
Ki 25 meas. best 7.16
Kd 7 meas. best 6.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H2 receptor CHEMBL1941 | Ki | 7.16 | 6.5157 | 70.0 | 7 |
| Histamine H2 receptor CHEMBL1941 | IC50 | 6.85 | 6.2356 | 140.0 | 9 |
| Histamine H2 receptor CHEMBL4654 | Kd | 6.6 | 6.6 | 251.2 | 2 |
| Histamine H2 receptor CHEMBL2882 | Kd | 6.58 | 6.286 | 263.0 | 5 |
| Histamine H2 receptor CHEMBL2882 | Ki | 6.52 | 6.3733 | 302.0 | 3 |
| Solute carrier family 22 member 1 CHEMBL2073664 | IC50 | 6.23 | 6.23 | 590.0 | 1 |
| Potassium-transporting ATPase CHEMBL2095173 | IC50 | 6.09 | 6.09 | 820.0 | 1 |
| Histamine H2 receptor CHEMBL2882 | IC50 | 5.99 | 5.99 | 1020.0 | 1 |
| Multidrug and toxin extrusion protein 1 CHEMBL1743126 | IC50 | 5.92 | 5.6067 | 1200.0 | 3 |
| Solute carrier family 22 member 1 CHEMBL2073670 | Ki | 5.24 | 5.24 | 5700.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL2073662 | IC50 | 5.1 | 5.1 | 8000.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1770032 | Ki | 5.03 | 5.03 | 9400.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 4.9 | 4.72 | 12589.2 | 2 |
| Cytochrome P450 3A4 CHEMBL340 | IC50 | 4.82 | 4.82 | 15000.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 4.7 | 4.7 | 20000.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1743122 | IC50 | 4.64 | 4.64 | 23000.0 | 1 |
| Multidrug and toxin extrusion protein 2 CHEMBL1743127 | IC50 | 4.41 | 4.41 | 39000.0 | 1 |
| Organic anion transporter 3 CHEMBL2073666 | Ki | 4.33 | 4.33 | 46800.0 | 1 |
| Organic anion transporter 3 CHEMBL1641348 | Ki | 4.28 | 4.28 | 53000.0 | 1 |
| Solute carrier family 22 member 2 CHEMBL1743122 | Ki | 4.24 | 4.24 | 57000.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | Ki | 4.11 | 4.11 | 77000.0 | 1 |
| Organic anion transporter 3 CHEMBL1641348 | IC50 | 4.03 | 4.03 | 92400.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 0.2 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.1 | mL.min-1.kg-1 | Homo sapiens |
| Cmax | 11900.0 | nM | Homo sapiens |
| F | 79.0 | % | Homo sapiens |
| F | 60.0 | % | Homo sapiens |
| F | 60.0 | % | Homo sapiens |
| Fu | 0.81 | - | - |
| Fu | 0.374 | - | - |
| Fu | 0.81 | - | Homo sapiens |
| Fu | 0.78 | - | Homo sapiens |
| Fu | 0.78 | - | Homo sapiens |
| Fu | 1.0 | - | Homo sapiens |
| Fu | 0.76 | - | Rattus norvegicus |
| MRT | 2.5 | hr | Homo sapiens |
| T1/2 | 2.2 | hr | Homo sapiens |
| Vd | 2.3 | L.kg-1 | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885861 | Rattus norvegicus | 1430 |
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 467 |
| - | 10.5281/zenodo.13943903 | ADMET | 89 |
| 31158845 | 10.1038/s41586-019-1291-3 | ADMET | 55 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 12699389 | 10.1021/jm021012t | ATP-dependent translocase ABCB1 | 13 |
| 21212239 | 10.1124/dmd.110.036780 | ADMET | 13 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 21051535 | 10.1124/dmd.110.034629 | ADMET | 9 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| - | 10.1007/s00044-004-0012-z | Rattus norvegicus | 8 |
| 6834386 | 10.1021/jm00358a015 | Canis familiaris | 6 |
| 3681897 | 10.1021/jm00395a015 | Rattus norvegicus | 5 |
| 11602674 | - | ATP-dependent translocase ABCB1 | 5 |
| 21599003 | 10.1021/jm2001629 | ADMET | 5 |
| 12061889 | 10.1021/jm0200409 | ADMET | 5 |
| 15658873 | 10.1021/jm049711o | ADMET | 5 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 6131126 | 10.1021/jm00355a001 | No relevant target | 4 |
Data from ChEMBL 36 via Core Engine